Saturday, September 13, 2014
Dr Ozturk received his BA in biology from Johns Hopkins University and his medical degree from the Yale University School of Medicine. He then completed a residency in neurosurgery at Yale-New Haven Hospital, and a fellowship in spine surgery at the Johns Hopkins Hospital.
Dr. Ozturk specializes in the treatment of brain tumors, brain trauma, and complex spinal disorders, including tumors, degenerative spine disease, trauma, and minimally invasive spine surgery.
His research efforts focus on spinal disease, including degenerative and oncologic disease processes and the genetic basis of diseases affecting the central nervous system. He has published extensively on the genetic basis of human disease and his work in this field has earned him numerous awards and grants from the Congress of Neurological Surgeons (CNS) and the American Association of Neurological Surgeons (AANS).
Dr. Ozturk is board certified in neurological surgery. He sees patients at Pennsylvania Hospital.
David K. Kung, MD, joins Penn Medicine as the newest member of Penn Neurology. Dr. Kung obtained his medical degree from the Albert Einstein College of Medicine in New York City and completed a residency in neurological surgery at the University of Iowa Hospitals and Clinics. Dr. Kung went on to complete fellowships in neurovascular surgery and endovascular neurosurgery at Thomas Jefferson University.
Dr. Kung has a specific clinical interest in neurovascular diseases, and is accomplished in microsurgical, radiosurgical, and endovascular techniques. He has, as well, a deep interest in neurovascular research. He has authored or co-authored more than 25 peer-reviewed articles and is actively engaged in the study of cerebral aneurysms, including the mechanisms of growth and rupture, and novel treatments for these anomalies.
Dr. Kung is board certified in neurological surgery and sees patients at the Hospital of the University of Pennsylvania.
Thursday, July 10, 2014
In addition to his new role, Dr. Parmacek is the Francis C. Wood professor of medicine and director of the Penn Cardiovascular Institute. A nationally recognized expert in cardiovascular biology and medicine, he has achieved significant research advances in his 16 years at Penn Medicine and has built one of the nation’s leading cardiovascular medicine programs. Over the course of his career, Dr. Parmacek has made multiple seminal discoveries that have impacted our understanding of the molecular and genetic basis of congenital heart disease, atherosclerosis, aortic aneurysm and dissection and heart failure. He has published a substantial body of scholarly work in journals including Science, the Proceedings of the National Academy of Science, Genes and Development and the New England Journal of Medicine.
Dr. Parmacek has served as an established investigator of the American Heart Association (AHA), president of the Association of Professors of Cardiology, fellow of the AHA and American College of Cardiology, and member of the American Society of Clinical Investigation and Association of American Physicians. He has been named to local, regional and national leadership positions with the advisory council of the National Institutes of Health/National Heart, Lung, and Blood Institute, as well as the Commonwealth of Pennsylvania Health Research advisory council.
About the Penn Medicine Department of Medicine
Penn’s Department of Medicine is responsible for more than 430,000 outpatient encounters and more than 25,000 inpatient admissions each year. This includes general internal medicine care for adults, as well as subspecialty care. Department subspecialty divisions include:
- Cardiovascular Medicine
- Endocrinology, Diabetes and Metabolism
- General Internal Medicine
- Infectious Diseases
- Pulmonary, Allergy and Critical Care
- Renal-Electrolyte and Hypertension
- Sleep Medicine
- Translational Medicine and Human Genetics
The Department of Medicine at Penn is the oldest in the country, with origins dating back to 1765 when John Morgan, MD, assumed leadership as the first department chair in the first medical school in the 13 American colonies. In the almost 250 years since it was established, Penn’s Department of Medicine has been served by 23 chairs.
Today, the Department includes 500 full-time faculty, more than 200 associated faculty and more than 300 academic support staff. The most recent NIH Report ranks the Department of Medicine at Penn #3 in funding among all departments of medicine in U.S. medical schools, with just over $110 million in grant support.
Friday, June 27, 2014
Subsequently, Dr. Khungar completed an internship and residency in Internal Medicine at New York University, where she remained for one year after her training as a Clinical Instructor. In this position she served as the internist for the NYU World Trade Center clinic. She then went on to complete a fellowship in Gastroenterology at the University of California Los Angeles (UCLA) and a fellowship in Transplant Hepatology at Columbia University.
Dr Khungar's areas of interest include liver transplantation, immunosuppression, hepatocellular cancer and benign tumors of the liver and care of the chronic liver disease patient. She sees patients at the Perelman Center for Advanced Medicine and the Hospital of the University of Pennsylvania.
Ranjeeta Bahirwani, MD, is a transplant hepatologist with the Division of Gastroenterology at Penn Medicine. A graduate of the Feinberg School of Medicine at Northwestern University, Dr Bahirwani completed her internship and residency in internal medicine at the Hospital of the University of Pennsylvania (HUP), where she subsequently completed fellowships in gastroenterology and transplant hepatology. She is currently the associate fellowship program director in transplant-hepatology at the Perelman School of Medicine.
Dr. Bahirwani’s research interests include post-transplant outcomes focusing on predictors of chronic kidney disease after liver transplantation; candidacy for simultaneous liver-kidney transplantation; ICU outcomes in patients with end-stage liver disease; and predictors of need for ICU care/ICU mortality.
She has authored articles in peer-reviewed journals and regularly presents at national meetings, including the American Transplant Congress and the annual meeting of the American Association for the Study of Liver Diseases.
Dr Bahirwani is board certified in internal medicine, gastroenterology and transplant-hepatology. She sees patients at the Perelman Center for Advanced Medicine.
Dr. Green’s clinical and research interests focus upon Crohn’s disease and ulcerative colitis. As a co-author he has contributed to review articles, book chapters and presentations on these subjects, as well as on pancreatitis, infectious disease and general gastroenterology. He has also lectured widely on inflammatory bowel disease and its complications.
Dr. Green has had a career-long interest in the quality assessment and improvement of gastrointestinal endoscopy in the hospital setting, and in the education and training of gastroenterology fellows, medical residents and medical students in general gastroenterology and gastrointestinal endoscopy, with an emphasis on IBD, where applicable.
Dr. Green is board-certified in internal medicine and gastroenterology. He will see patients at Penn Presbyterian Medical Center beginning in May 2014.
Friday, May 30, 2014
Anthony R. Mato, MD, MSCE, has joined the Division of Hematology/Oncology at Penn Medicine as an Assistant Professor of Medicine.
Dr. Mato received his medical degree from the from the State University of New York (SUNY) at Buffalo School of Medicine. He completed a residency in Internal Medicine and a fellowship in Hematology/Oncology at the Hospital of the University of Pennsylvania. Among other awards, Dr Mato has received both the Siegel Teaching Award from SUNY Buffalo School of Medicine and the Jane Alvai Award from the University of Pennsylvania.
Dr Mato is board certified in internal medicine, hematology and medical oncology. He will see patients at the new Center for Chronic Lymphocytic Leukemia at the Abramson Cancer Center.
The Center for Chronic Lymphocytic Leukemia provides consultation for patients with new and previously diagnosed CLL, assists in detailed clinical and molecular prognostic testing, and provides outstanding clinical care personalized to each patient’s needs.
To schedule an appointment with Dr. Mato or any of our other CLL experts, call 800.789.PENN (7366) or request an appointment online.
Wednesday, May 14, 2014
Penn Heart & Vascular Welcomes Satoshi Furukawa, MD, FACS, New Chief of Cardiovascular Surgery at Pennsylvania Hospital
Dr. Furukawa specializes in open and minimally invasive surgery, cardiac and lung transplantation, LVRS, mitral valve repair, TAVR, aortic surgery, off-pump bypass surgery, bullectomy and long-term mechanical circulatory support. He also has an interest in stress management and alternative surgery after surgery.
His other clinical specialties include minimally invasive cardiac surgery, high risk cardiac surgery (aortic, mitral and redo), and off-pump ventricular assist device implantation surgery. He is certified by the Joint Commission to perform lung volume reduction surgery to treat emphysema, and he is a United Network for Organ Sharing (UNOS)-approved heart and lung transplant surgeon. Dr. Furukawa has performed more than 400 heart transplants and 120 lung transplants.
Dr. Furukawa previously served as a cardiothoracic surgeon and professor of surgery at Temple University Hospital and chief of cardiothoracic surgery at The Reading Hospital and Medical Center
Upon receiving his medical degree from the University of Pennsylvania School of Medicine, Dr. Furukawa completed residencies in general and cardiothoracic surgery at the Hospital of the University of Pennsylvania. He went on to complete fellowships in lung transplantation at the Hospital of the University of Pennsylvania and Temple University Hospital. Dr. Furukawa is board certified in thoracic surgery and general surgery, and he has participated in several clinical studies.
Learn more about the Cardiovascular Surgery Program at Penn Medicine. To schedule an appointment with Dr.Furukawa, call 800-789-PENN (7366) or request an appointment online.
Friday, January 17, 2014
Paul J. Foley III, MD, joins the division of vascular surgery and endovascular therapy as an assistant professor of surgery. His clinical interests include aortic surgery, carotid endarterectomy and stenting, and peripheral arterial disease.
Upon receiving his medical degree from the University of Pennsylvania school of medicine, Dr. Foley completed his internship at New York-Presbyterian Hospital/ columbia University medical center. He completed his residency at the Hospital of the University of Pennsylvania, where he also served as a post-doctoral research fellow in the department of surgery. He went on to complete a fellowship in vascular surgery and endovascular therapy at the Hospital of the University of Pennsylvania. Dr. Foley is board certified in general surgery and vascular surgery.
Penn’s Vascular surgery and endovascular Therapy team offers patients the most fully integrated and comprehensive care programs for vascular disease in the Philadelphia region. Penn is among a handful of centers at the forefront of endovascular surgery and performs more carotid, aortic, and peripheral arterial repairs than any other regional facility.
Learn more about vascular surgery and endovascular therapy services at Penn Medicine. To schedule an appointment with Dr. Foley, call 800-789-PENN (7366) or request an appointment online.
Wednesday, December 18, 2013
Penn Medicine is pleased to welcome Fiona Simpkins, MD, to the department of obstetrics and gynecology and division of gynecologic oncology as an assistant professor of obstetrics and gynecology.
Dr. Simpkins specializes in the evaluation and management of women with gynecologic malignancies, including ovarian, uterine, vulvar and cervical cancers. Her primary research goals are to develop novel strategies and new molecular targets for the treatment of gynecologic malignancies and understand the role of cancer stem cells in ovarian cancer.
Dr. Simpkins is a graduate of the University of California, Los Angeles, and Temple University School of Medicine. She completed a residency in obstetrics and gynecology at Johns Hopkins University Hospital and a gynecology oncology fellowship at the Cleveland Clinic. She is board certified in obstetrics and gynecology and gynecologic oncology and is a member of the Society of Gynecologic Oncology, American College of Obstetrics and Gynecology and American Society of Clinical Oncologists.